NK cell immunotherapy: what’s next in clinical development?
European Pharmaceutical Review
DECEMBER 12, 2023
Pharmaceutical companies such as Sanofi and AstraZeneca are currently conducting several high-potential clinical development programmes in oncology in collaboration with Innate Pharma. In 2007, he became in charge for business development and in 2017, also became responsible of the portfolio strategy.
Let's personalize your content